On this page
What should CTD P.6 explain about product reference standards?
Map the reference materials actually used by finished-product methods to their identity, assigned values and qualification evidence. Cross-reference S.5 only where that information supports the intended product use. Describe product-specific standards and relevant lot changes so every assay can be traced to the material anchoring its result.
Before you begin
M4Q(R1) P.6, including reference materials not already adequately described in S.5.
What you will prepare: A concise product-reference section with explicit assay uses and traceable qualification or cross-references.
Start with the product assays, not the substance inventory
Review P.5's procedures and list the actual reference materials used in finished-product testing. Identify which are already described in S.5 and which are product-specific, such as a formulation-related degradant or activity reference. For each, record the intended assay, identity, source/lot, assigned value and qualification evidence from controlled laboratory records.
M4Q allows information already provided in S.5 to be referenced. Reuse it with a precise statement of applicability, not a blanket “see S.5” that leaves product-specific standards unaddressed. Confirm that the referenced material's value and qualification support the intended product assay and calculation.
Explain new materials and bridge relevant changes
For material not covered elsewhere, present the identification and qualification supporting its use. Reconcile storage/validity controls and assigned-value basis with the laboratory records and analytical method. Explain relevant transitions between lots when interpreting development, release or stability data. A new lot number in the latest certificate can matter if the data package spans older lots.
Fictional exercise: the product degradation assay uses a degradant reference absent from S.5, yet P.6 contains only a cross-reference. Add the actual reference-material information after obtaining its identity and qualification records. If they are unavailable, identify the analytical evidence gap and its impact on P.5/P.8 rather than inventing a purity assignment. Finish by testing whether a reviewer can trace each P.5 assay to the material it uses.
Check reference coverage method by method
P.6 can be short when precise cross-references genuinely cover the materials used. It should not be short because product-specific standards have been overlooked.
| Product method | Reference information to locate | Coverage decision |
|---|---|---|
| Assay or potency | Actual material, lot and assigned-value basis | Does the S.5 record support this calculation and use? |
| Degradation measurement | Relevant degradant identity and qualification | Is a separate product-related material needed in the description? |
| Biological or performance-related method | Intended analytical role and assignment evidence | Does a generic purity certificate answer the real question? |
| Results across lot changes | Materials used at each stage and supporting relationship | Can the analytical owner explain the continuity of interpretation? |
This is an editorial coverage review, not a new qualification protocol. If information is shared with S.5, reference the exact material and relevant scope. Where the product assay uses another standard, obtain its actual records rather than stretching the reference to cover an absent item.
Fictional review: initial stability results used reference lot A, while later testing used lot B with a differently expressed assigned value. Record the lots and calculation bases beside the method history, then ask the analytical owner whether the apparent trend is interpretable as written. Do not independently rescale reported data.
Reconcile the result with P.5 analytical controls and P.8 stability. A correct cross-reference should save duplication while preserving traceability, not shift the unresolved question to another section.
Your preparation checklist
0/3 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Can P.6 contain only a reference to S.5?
That can be appropriate only when the referenced information actually covers the materials and intended product uses. Check every relevant P.5 method first. Product-specific degradants or other reference materials absent from S.5 still need their applicable information addressed.
Does an unchanged reference name make a new lot interchangeable?
Not automatically. Identify the actual lot, assignment and qualification relationship relevant to the method. Where results span a lot change, obtain the analytical assessment needed to interpret them consistently rather than assuming that the shared name settles the comparison.
Should the writer recalculate results when the reference basis looks wrong?
No. Record the discrepancy and involve the responsible laboratory and analytical owners through the controlled review process. Determine whether data or interpretation are affected, then update the dossier from the resolved records. An editorial correction is not a substitute for an analytical investigation.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Guidance
ICH M4Q(R1): CTD Quality ↗Step 4, September 12, 2002; Module 3, printed pages 5–18. Organization/content guidance, not a universal list of required studies. Checked September 22, 2026. Guide-specific passages: 3.2.P.6, printed page 15.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 3.2.P.6. A heading identifies placement, not mandatory applicability.